Pnc Financial Services Group, Inc. Dbv Technologies S.A. Transaction History

Pnc Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.39 - $5.58 $10,206 - $40,973	-7,343 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$4.71 - $5.92 $34,585 - $43,470	7,343 New	7,343 $35,000
Q4 2017 Feb 09, 2018	SELL	$20.9 - $49.36 $209,000 - $493,600	-10,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$39.62 - $46.17 $396,200 - $461,700	10,000	10,000 $0

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $792M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.